These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 16625566

  • 1. Inhaled hyperosmolar agents for bronchiectasis.
    Wills P, Greenstone M.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD002996. PubMed ID: 16625566
    [Abstract] [Full Text] [Related]

  • 2. Inhaled hyperosmolar agents for bronchiectasis.
    Wills P, Greenstone M.
    Cochrane Database Syst Rev; 2002 Apr 19; (1):CD002996. PubMed ID: 11869647
    [Abstract] [Full Text] [Related]

  • 3. Inhaled hyperosmolar agents for bronchiectasis.
    Wills P, Greenstone M.
    Cochrane Database Syst Rev; 2001 Apr 19; (2):CD002996. PubMed ID: 11406058
    [Abstract] [Full Text] [Related]

  • 4. Inhaled hyperosmolar agents for bronchiectasis.
    Hart A, Sugumar K, Milan SJ, Fowler SJ, Crossingham I.
    Cochrane Database Syst Rev; 2014 May 12; 2014(5):CD002996. PubMed ID: 24817558
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis.
    Daviskas E, Anderson SD, Eberl S, Chan HK, Bautovich G.
    Am J Respir Crit Care Med; 1999 Jun 12; 159(6):1843-8. PubMed ID: 10351929
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dornase alfa for cystic fibrosis.
    Yang C, Chilvers M, Montgomery M, Nolan SJ.
    Cochrane Database Syst Rev; 2016 Apr 04; 4():CD001127. PubMed ID: 27043279
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic agents for mucus clearance in bronchiectasis.
    Nair GB, Ilowite JS.
    Clin Chest Med; 2012 Jun 04; 33(2):363-70. PubMed ID: 22640851
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
    Daviskas E, Anderson SD, Eberl S, Young IH.
    Respir Med; 2010 Nov 04; 104(11):1645-53. PubMed ID: 20576419
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M, Dentice R.
    Cochrane Database Syst Rev; 2012 Feb 15; (2):CD008816. PubMed ID: 22336853
    [Abstract] [Full Text] [Related]

  • 18. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA, McDonald V.
    Cochrane Database Syst Rev; 2000 Feb 15; (2):CD001506. PubMed ID: 10796798
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M, Dentice R.
    Cochrane Database Syst Rev; 2016 Dec 15; 12(12):CD008816. PubMed ID: 28146603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.